About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study Looking at Biomarkers in Ovarian Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT03419689

Study Looking at Biomarkers in Ovarian Cancer

This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the results of t...

Lead sponsor: University Health Network, Toronto•7 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Amit Oza, M.D.

CONTACT

416-946-2818 [email protected]

Sponsors

Lead Sponsor

University Health Network, Toronto

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer.
•Must be 18 years of age or older.
•Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.
•Have a life expectancy greater than or equal to 6 months.
•Able to provide adequate informed consent.
•Willing to undergo blood or fluid collection and tumour biopsy
•Patients enrolled at the time of surgery must agree to have part of their tumour used for the purpose of the study.
•Archival tissue must be available for patients that are enrolled at the time of progression.

Exclusion Criteria

•Must not have early stage (I and II) high grade serous, tubal or primary peritoneal cancer.
•Must not have other tumour histology other than high grade serous.
•Must not have contraindication to tumour biopsy and/or blood sampling.

Related studies

RECRUITINGPhase 2

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

NCT05787561 · Mesonephric Gynecologic Cancer

RECRUITINGPhase 2

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

NCT07447050 · Breast Cancer, Sarcoma, and more

Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

NCT07416630 · Gynecologic Cancer, Urologic Cancer, and more

Proactive Costs of Care Study

NCT07217262 · Financial Burden, Financial Toxicity, and more

RECRUITINGPhase 1

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

NCT07055854 · Gynecologic Cancers, Breast Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 4, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment510

Start dateJan 2018

Last updatedDec 4, 2025

Condition

Gynecologic Cancer

Locations shown

Royal Victoria Regional Health Centre

Barrie, Ontario

Juravinski Cancer Centre

Hamilton, Ontario

Kingston Health Sciences Centre

Kingston, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 4, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions